metastasis

Advertisement
Patrick DalyBreast Cancer News | April 11, 2023
Researchers, led by Joana Reis, examined the diagnostic accuracy of magnetic resonance imaging (MRI) for detecting ...
Read More
Rob DillardLung Cancer | September 21, 2023
A new study shows that patients with primary lung cancer detected using low-dose computed tomography (LDCT) screening ...
Kerri FitzgeraldBreast Cancer News | April 25, 2023
The U.S. Food and Drug Administration approved Trodelvy™ (sacituzumab govitecan-hziy) for patients with metastatic ...
Kerri FitzgeraldOncology | April 25, 2023
The U.S. Food and Drug Administration (FDA) approved a supplemental new drug application for Xtandi® (enzalutamide) for ...
Rob DillardOncology | April 25, 2023
Melanoma of the eye may soon be detected using a simple test, according to a study that appeared in Translational Vision ...
Rob DillardOncology | April 25, 2023
Do you have questions about cancer? Many of us do, as it’s always best to ask them. Staying informed about cancer can ...
Victoria SochaASCO 2019 | April 25, 2023
In patients with renal cell carcinoma (RCC) with low tumor burden or slow growing disease, active surveillance is a ...
Kerri FitzgeraldBreast Cancer News | April 25, 2023
The U.S. Food and Drug Administration (FDA) granted orphan drug designation to Nerlynx® (neratinib) for patients with ...
DocWire News EditorsOncology | August 22, 2019
Scientists from the Paul Scherrer Institute (PSI) have recently teamed up with pharma company F. Hoffmann-La Roche AG to ...
DocWire News EditorsOvarian Cancer | April 11, 2023
By combining microscopy with algorithms that can differentiate between healthy and malignant tissues from images, ...
Rob DillardOncology | April 25, 2023
Optimism among patients with terminal cancer is a psychological state that can become contagious and have a negative ...
Kerri FitzgeraldOncology | April 25, 2023
The U.S. Food and Drug Administration (FDA) approved erdafitinib (BALVERSA™) for the treatment of adults with ...
Kerri FitzgeraldSkin Cancer | November 7, 2024
Results from the open-label, phase II CheckMate 204 study show that combined immunotherapy with the two checkpoint ...
Advertisement
Advertisement
Advertisement
Latest News

March 19, 2025